Cathodal Iontophoresis of Treprostinil Induces a Sustained Increase in Cutaneous Blood Flux in Healthy Volunteers
Article first published online: 24 JAN 2013
© 2012 The Author(s)
The Journal of Clinical Pharmacology
Volume 53, Issue 1, pages 58–66, January 2013
How to Cite
Blaise, S., Roustit, M., Hellmann, M., Millet, C. and Cracowski, J.-L. (2013), Cathodal Iontophoresis of Treprostinil Induces a Sustained Increase in Cutaneous Blood Flux in Healthy Volunteers. Journal of Clinical Pharma, 53: 58–66. doi: 10.1177/0091270011434352
- Issue published online: 8 FEB 2013
- Article first published online: 24 JAN 2013
- Manuscript Accepted: 9 NOV 2011
- Manuscript Received: 7 JUL 2011
- prostaglandin I2;
- prostaglandin analogue;
Prostacyclin analogues are the most effective drugs to treat sclerodermic digital ulcers, but their systemic use is limited by their frequent side effects. The authors tested whether the prostacyclin analogues treprostinil and iloprost, delivered by cutaneous iontophoresis, induce sustained vasodilatation.
Twenty healthy volunteers received treprostinil by cathodal iontophoresis on the forearm. Skin blood flux was quantified using laser Doppler imaging.
Treprostinil 250 µM induced an increase in cutaneous vascular conductance AUC80 min (31 897 ± 24 390 %BL·min) compared with NaCl 0.9% (P < .005), treprostinil 2.5 µM (P < .005), and treprostinil 25 µM (P < .005). This was confirmed when flux was recorded for up to 10 hours. Systemic and skin tolerance of treprostinil were good. Iloprost was stopped early because of local toxicity.
Treprostinil cathodal iontophoresis induces a sustained increase in cutaneous blood flow with good local tolerance. This could be investigated as a new local therapy for digital ulcers in scleroderma.